Aurobindo Pharma Reports 24 Percent Revenue Growth in Q2 FY27
Aurobindo Pharma has reported 24 percent year-on-year revenue growth to INR 10,263 crore for Q2 FY27, with net profit reaching INR 1,124 crore.
Healthcare Worldwide | 05/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy